nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—SLC6A4—Alzheimer's disease	0.451	1	CbGaD
Sibutramine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0751	0.432	CbGbCtD
Sibutramine—CYP3A4—Donepezil—Alzheimer's disease	0.0601	0.345	CbGbCtD
Sibutramine—CYP3A4—Galantamine—Alzheimer's disease	0.0387	0.223	CbGbCtD
Sibutramine—SLC6A2—locus ceruleus—Alzheimer's disease	0.0119	0.316	CbGeAlD
Sibutramine—SLC6A3—telencephalic ventricle—Alzheimer's disease	0.00697	0.186	CbGeAlD
Sibutramine—SLC6A3—Alpha-synuclein signaling—KLK6—Alzheimer's disease	0.0023	0.0587	CbGpPWpGaD
Sibutramine—SLC6A3—forebrain—Alzheimer's disease	0.00182	0.0486	CbGeAlD
Sibutramine—SLC6A3—telencephalon—Alzheimer's disease	0.00167	0.0447	CbGeAlD
Sibutramine—SLC6A4—forebrain—Alzheimer's disease	0.00167	0.0445	CbGeAlD
Sibutramine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—Alzheimer's disease	0.00166	0.0423	CbGpPWpGaD
Sibutramine—SLC6A4—telencephalon—Alzheimer's disease	0.00153	0.0409	CbGeAlD
Sibutramine—SLC6A2—forebrain—Alzheimer's disease	0.00147	0.0392	CbGeAlD
Sibutramine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—Alzheimer's disease	0.00144	0.0369	CbGpPWpGaD
Sibutramine—SLC6A2—telencephalon—Alzheimer's disease	0.00135	0.036	CbGeAlD
Sibutramine—SLC6A4—Synaptic Vesicle Pathway—SYP—Alzheimer's disease	0.0013	0.0333	CbGpPWpGaD
Sibutramine—SLC6A4—Synaptic Vesicle Pathway—SLC18A3—Alzheimer's disease	0.00106	0.0272	CbGpPWpGaD
Sibutramine—SLC6A3—nervous system—Alzheimer's disease	0.000988	0.0264	CbGeAlD
Sibutramine—SLC6A4—Monoamine Transport—PVRL2—Alzheimer's disease	0.000958	0.0245	CbGpPWpGaD
Sibutramine—SLC6A3—central nervous system—Alzheimer's disease	0.000952	0.0254	CbGeAlD
Sibutramine—SLC6A3—cerebellum—Alzheimer's disease	0.00093	0.0248	CbGeAlD
Sibutramine—SLC6A4—nervous system—Alzheimer's disease	0.000906	0.0242	CbGeAlD
Sibutramine—SLC6A3—Alpha-synuclein signaling—SNCA—Alzheimer's disease	0.000897	0.0229	CbGpPWpGaD
Sibutramine—SLC6A4—central nervous system—Alzheimer's disease	0.000872	0.0233	CbGeAlD
Sibutramine—SLC6A3—Parkinsons Disease Pathway—LRRK2—Alzheimer's disease	0.00085	0.0217	CbGpPWpGaD
Sibutramine—SLC6A2—Monoamine Transport—PVRL2—Alzheimer's disease	0.000824	0.0211	CbGpPWpGaD
Sibutramine—SLC6A2—nervous system—Alzheimer's disease	0.000797	0.0213	CbGeAlD
Sibutramine—SLC6A2—central nervous system—Alzheimer's disease	0.000768	0.0205	CbGeAlD
Sibutramine—SLC6A3—Parkinsons Disease Pathway—SNCA—Alzheimer's disease	0.000762	0.0195	CbGpPWpGaD
Sibutramine—SLC6A3—brain—Alzheimer's disease	0.000756	0.0202	CbGeAlD
Sibutramine—SLC6A3—Monoamine Transport—PVRL2—Alzheimer's disease	0.00073	0.0186	CbGpPWpGaD
Sibutramine—SLC6A4—Monoamine Transport—ACHE—Alzheimer's disease	0.000717	0.0183	CbGpPWpGaD
Sibutramine—SLC6A3—Alpha-synuclein signaling—MAOB—Alzheimer's disease	0.000693	0.0177	CbGpPWpGaD
Sibutramine—SLC6A4—brain—Alzheimer's disease	0.000692	0.0185	CbGeAlD
Sibutramine—SLC6A2—Monoamine Transport—ACHE—Alzheimer's disease	0.000617	0.0158	CbGpPWpGaD
Sibutramine—SLC6A2—brain—Alzheimer's disease	0.00061	0.0163	CbGeAlD
Sibutramine—SLC6A2—Monoamine Transport—SLC6A4—Alzheimer's disease	0.000567	0.0145	CbGpPWpGaD
Sibutramine—SLC6A4—Serotonin Transporter Activity—IL1B—Alzheimer's disease	0.000563	0.0144	CbGpPWpGaD
Sibutramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A6—Alzheimer's disease	0.000547	0.014	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—ACHE—Alzheimer's disease	0.000546	0.014	CbGpPWpGaD
Sibutramine—SLC6A3—Alpha-synuclein signaling—PTK2B—Alzheimer's disease	0.000515	0.0132	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—SLC6A4—Alzheimer's disease	0.000502	0.0128	CbGpPWpGaD
Sibutramine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A6—Alzheimer's disease	0.000484	0.0124	CbGpPWpGaD
Sibutramine—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	0.000466	0.0119	CbGpPWpGaD
Sibutramine—CYP3A4—nervous system—Alzheimer's disease	0.000444	0.0118	CbGeAlD
Sibutramine—CYP3A4—central nervous system—Alzheimer's disease	0.000427	0.0114	CbGeAlD
Sibutramine—CYP3A4—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.000389	0.00994	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.00036	0.00921	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC24A4—Alzheimer's disease	0.000358	0.00916	CbGpPWpGaD
Sibutramine—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.000335	0.00856	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC24A4—Alzheimer's disease	0.000318	0.00812	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.000306	0.00783	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.000306	0.00783	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.000297	0.00758	CbGpPWpGaD
Sibutramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Alzheimer's disease	0.000292	0.00746	CbGpPWpGaD
Sibutramine—CYP3A4—Irinotecan Pathway—BCHE—Alzheimer's disease	0.000282	0.00722	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—SLC18A3—Alzheimer's disease	0.000272	0.00694	CbGpPWpGaD
Sibutramine—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.000269	0.00689	CbGpPWpGaD
Sibutramine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.000268	0.00684	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.00026	0.00666	CbGpPWpGaD
Sibutramine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Alzheimer's disease	0.000259	0.00661	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC30A6—Alzheimer's disease	0.000248	0.00635	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.000245	0.00626	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.00024	0.00614	CbGpPWpGaD
Sibutramine—SLC6A4—Monoamine Transport—IL1B—Alzheimer's disease	0.00024	0.00613	CbGpPWpGaD
Sibutramine—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	0.000224	0.00572	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC30A6—Alzheimer's disease	0.00022	0.00563	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.00022	0.00562	CbGpPWpGaD
Sibutramine—Anxiety—Galantamine—Alzheimer's disease	0.000219	0.000733	CcSEcCtD
Sibutramine—Sinusitis—Memantine—Alzheimer's disease	0.000218	0.00073	CcSEcCtD
Sibutramine—Sweating—Rivastigmine—Alzheimer's disease	0.000218	0.00073	CcSEcCtD
Sibutramine—Discomfort—Galantamine—Alzheimer's disease	0.000217	0.000727	CcSEcCtD
Sibutramine—Haematuria—Rivastigmine—Alzheimer's disease	0.000216	0.000726	CcSEcCtD
Sibutramine—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000215	0.00551	CbGpPWpGaD
Sibutramine—Dry mouth—Galantamine—Alzheimer's disease	0.000215	0.00072	CcSEcCtD
Sibutramine—Epistaxis—Rivastigmine—Alzheimer's disease	0.000214	0.000718	CcSEcCtD
Sibutramine—Tinnitus—Donepezil—Alzheimer's disease	0.000214	0.000717	CcSEcCtD
Sibutramine—Sinusitis—Rivastigmine—Alzheimer's disease	0.000213	0.000714	CcSEcCtD
Sibutramine—Confusional state—Galantamine—Alzheimer's disease	0.000212	0.000711	CcSEcCtD
Sibutramine—Bradycardia—Memantine—Alzheimer's disease	0.000212	0.000711	CcSEcCtD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—APOD—Alzheimer's disease	0.000211	0.0054	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.00021	0.00536	CbGpPWpGaD
Sibutramine—Haemoglobin—Memantine—Alzheimer's disease	0.000209	0.000702	CcSEcCtD
Sibutramine—Rhinitis—Memantine—Alzheimer's disease	0.000209	0.0007	CcSEcCtD
Sibutramine—Haemorrhage—Memantine—Alzheimer's disease	0.000208	0.000699	CcSEcCtD
Sibutramine—SLC6A3—Neuronal System—SLC18A3—Alzheimer's disease	0.000208	0.00532	CbGpPWpGaD
Sibutramine—Bradycardia—Rivastigmine—Alzheimer's disease	0.000207	0.000696	CcSEcCtD
Sibutramine—Hypoaesthesia—Memantine—Alzheimer's disease	0.000207	0.000695	CcSEcCtD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000207	0.00529	CbGpPWpGaD
Sibutramine—Shock—Galantamine—Alzheimer's disease	0.000207	0.000694	CcSEcCtD
Sibutramine—Pharyngitis—Memantine—Alzheimer's disease	0.000207	0.000693	CcSEcCtD
Sibutramine—SLC6A2—Monoamine Transport—IL1B—Alzheimer's disease	0.000206	0.00527	CbGpPWpGaD
Sibutramine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000206	0.000691	CcSEcCtD
Sibutramine—Chills—Donepezil—Alzheimer's disease	0.000206	0.00069	CcSEcCtD
Sibutramine—Tachycardia—Galantamine—Alzheimer's disease	0.000205	0.000689	CcSEcCtD
Sibutramine—Oedema peripheral—Memantine—Alzheimer's disease	0.000205	0.000688	CcSEcCtD
Sibutramine—Arrhythmia—Donepezil—Alzheimer's disease	0.000205	0.000687	CcSEcCtD
Sibutramine—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000205	0.000687	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.000204	0.00522	CbGpPWpGaD
Sibutramine—Rhinitis—Rivastigmine—Alzheimer's disease	0.000204	0.000685	CcSEcCtD
Sibutramine—Skin disorder—Galantamine—Alzheimer's disease	0.000204	0.000685	CcSEcCtD
Sibutramine—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000204	0.000684	CcSEcCtD
Sibutramine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000203	0.000682	CcSEcCtD
Sibutramine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000203	0.00068	CcSEcCtD
Sibutramine—Alopecia—Donepezil—Alzheimer's disease	0.000203	0.00068	CcSEcCtD
Sibutramine—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000202	0.000678	CcSEcCtD
Sibutramine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000201	0.000673	CcSEcCtD
Sibutramine—Visual impairment—Memantine—Alzheimer's disease	0.000201	0.000673	CcSEcCtD
Sibutramine—Anorexia—Galantamine—Alzheimer's disease	0.0002	0.000672	CcSEcCtD
Sibutramine—Malnutrition—Donepezil—Alzheimer's disease	0.0002	0.00067	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.0002	0.0051	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000197	0.00505	CbGpPWpGaD
Sibutramine—Flatulence—Donepezil—Alzheimer's disease	0.000197	0.00066	CcSEcCtD
Sibutramine—Hypotension—Galantamine—Alzheimer's disease	0.000196	0.000659	CcSEcCtD
Sibutramine—Visual impairment—Rivastigmine—Alzheimer's disease	0.000196	0.000659	CcSEcCtD
Sibutramine—Tension—Donepezil—Alzheimer's disease	0.000196	0.000657	CcSEcCtD
Sibutramine—Dysgeusia—Donepezil—Alzheimer's disease	0.000196	0.000656	CcSEcCtD
Sibutramine—Eye disorder—Memantine—Alzheimer's disease	0.000195	0.000653	CcSEcCtD
Sibutramine—Tinnitus—Memantine—Alzheimer's disease	0.000194	0.000651	CcSEcCtD
Sibutramine—Nervousness—Donepezil—Alzheimer's disease	0.000194	0.000651	CcSEcCtD
Sibutramine—Back pain—Donepezil—Alzheimer's disease	0.000193	0.000648	CcSEcCtD
Sibutramine—Muscle spasms—Donepezil—Alzheimer's disease	0.000192	0.000644	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000192	0.000643	CcSEcCtD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GRIK1—Alzheimer's disease	0.000191	0.00489	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—CHRNA7—Alzheimer's disease	0.000191	0.00489	CbGpPWpGaD
Sibutramine—Eye disorder—Rivastigmine—Alzheimer's disease	0.00019	0.000639	CcSEcCtD
Sibutramine—Insomnia—Galantamine—Alzheimer's disease	0.00019	0.000638	CcSEcCtD
Sibutramine—Tinnitus—Rivastigmine—Alzheimer's disease	0.00019	0.000637	CcSEcCtD
Sibutramine—Angiopathy—Memantine—Alzheimer's disease	0.000189	0.000634	CcSEcCtD
Sibutramine—Paraesthesia—Galantamine—Alzheimer's disease	0.000189	0.000633	CcSEcCtD
Sibutramine—Vision blurred—Donepezil—Alzheimer's disease	0.000188	0.000631	CcSEcCtD
Sibutramine—Immune system disorder—Memantine—Alzheimer's disease	0.000188	0.000631	CcSEcCtD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—APOD—Alzheimer's disease	0.000187	0.00478	CbGpPWpGaD
Sibutramine—Tremor—Donepezil—Alzheimer's disease	0.000187	0.000628	CcSEcCtD
Sibutramine—Somnolence—Galantamine—Alzheimer's disease	0.000187	0.000627	CcSEcCtD
Sibutramine—Chills—Memantine—Alzheimer's disease	0.000187	0.000627	CcSEcCtD
Sibutramine—Arrhythmia—Memantine—Alzheimer's disease	0.000186	0.000624	CcSEcCtD
Sibutramine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000185	0.000622	CcSEcCtD
Sibutramine—Dyspepsia—Galantamine—Alzheimer's disease	0.000185	0.000621	CcSEcCtD
Sibutramine—Angiopathy—Rivastigmine—Alzheimer's disease	0.000185	0.00062	CcSEcCtD
Sibutramine—Anaemia—Donepezil—Alzheimer's disease	0.000185	0.000619	CcSEcCtD
Sibutramine—Alopecia—Memantine—Alzheimer's disease	0.000184	0.000617	CcSEcCtD
Sibutramine—Agitation—Donepezil—Alzheimer's disease	0.000183	0.000616	CcSEcCtD
Sibutramine—Chills—Rivastigmine—Alzheimer's disease	0.000183	0.000613	CcSEcCtD
Sibutramine—Decreased appetite—Galantamine—Alzheimer's disease	0.000183	0.000613	CcSEcCtD
Sibutramine—SLC6A3—Monoamine Transport—IL1B—Alzheimer's disease	0.000183	0.00467	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000182	0.00466	CbGpPWpGaD
Sibutramine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000182	0.000611	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000182	0.000609	CcSEcCtD
Sibutramine—Malnutrition—Memantine—Alzheimer's disease	0.000181	0.000608	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.000181	0.00463	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.000181	0.00462	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.000181	0.00462	CbGpPWpGaD
Sibutramine—Malaise—Donepezil—Alzheimer's disease	0.00018	0.000604	CcSEcCtD
Sibutramine—Alopecia—Rivastigmine—Alzheimer's disease	0.00018	0.000604	CcSEcCtD
Sibutramine—Constipation—Galantamine—Alzheimer's disease	0.00018	0.000603	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—CST3—Alzheimer's disease	0.00018	0.00459	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—CHRNB2—Alzheimer's disease	0.00018	0.00459	CbGpPWpGaD
Sibutramine—Vertigo—Donepezil—Alzheimer's disease	0.000179	0.000602	CcSEcCtD
Sibutramine—Syncope—Donepezil—Alzheimer's disease	0.000179	0.000601	CcSEcCtD
Sibutramine—Flatulence—Memantine—Alzheimer's disease	0.000179	0.000599	CcSEcCtD
Sibutramine—Tension—Memantine—Alzheimer's disease	0.000178	0.000597	CcSEcCtD
Sibutramine—Dysgeusia—Memantine—Alzheimer's disease	0.000178	0.000596	CcSEcCtD
Sibutramine—Malnutrition—Rivastigmine—Alzheimer's disease	0.000177	0.000595	CcSEcCtD
Sibutramine—Nervousness—Memantine—Alzheimer's disease	0.000176	0.000591	CcSEcCtD
Sibutramine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000175	0.000589	CcSEcCtD
Sibutramine—Back pain—Memantine—Alzheimer's disease	0.000175	0.000588	CcSEcCtD
Sibutramine—Flatulence—Rivastigmine—Alzheimer's disease	0.000175	0.000586	CcSEcCtD
Sibutramine—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	0.000174	0.00446	CbGpPWpGaD
Sibutramine—Cough—Donepezil—Alzheimer's disease	0.000174	0.000585	CcSEcCtD
Sibutramine—Tension—Rivastigmine—Alzheimer's disease	0.000174	0.000584	CcSEcCtD
Sibutramine—SLC6A4—Monoamine Transport—TNF—Alzheimer's disease	0.000174	0.00444	CbGpPWpGaD
Sibutramine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000174	0.000583	CcSEcCtD
Sibutramine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000173	0.000581	CcSEcCtD
Sibutramine—Convulsion—Donepezil—Alzheimer's disease	0.000173	0.00058	CcSEcCtD
Sibutramine—Hypertension—Donepezil—Alzheimer's disease	0.000172	0.000578	CcSEcCtD
Sibutramine—Nervousness—Rivastigmine—Alzheimer's disease	0.000172	0.000578	CcSEcCtD
Sibutramine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000172	0.000577	CcSEcCtD
Sibutramine—Back pain—Rivastigmine—Alzheimer's disease	0.000172	0.000576	CcSEcCtD
Sibutramine—Vision blurred—Memantine—Alzheimer's disease	0.000171	0.000573	CcSEcCtD
Sibutramine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000171	0.000572	CcSEcCtD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.00017	0.00435	CbGpPWpGaD
Sibutramine—Chest pain—Donepezil—Alzheimer's disease	0.00017	0.00057	CcSEcCtD
Sibutramine—Myalgia—Donepezil—Alzheimer's disease	0.00017	0.00057	CcSEcCtD
Sibutramine—Arthralgia—Donepezil—Alzheimer's disease	0.00017	0.00057	CcSEcCtD
Sibutramine—Tremor—Memantine—Alzheimer's disease	0.00017	0.00057	CcSEcCtD
Sibutramine—Anxiety—Donepezil—Alzheimer's disease	0.000169	0.000568	CcSEcCtD
Sibutramine—SLC6A2—NRF2 pathway—SLC6A4—Alzheimer's disease	0.000168	0.0043	CbGpPWpGaD
Sibutramine—Ill-defined disorder—Memantine—Alzheimer's disease	0.000168	0.000564	CcSEcCtD
Sibutramine—Discomfort—Donepezil—Alzheimer's disease	0.000168	0.000563	CcSEcCtD
Sibutramine—Anaemia—Memantine—Alzheimer's disease	0.000168	0.000562	CcSEcCtD
Sibutramine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000167	0.000561	CcSEcCtD
Sibutramine—Agitation—Memantine—Alzheimer's disease	0.000167	0.000559	CcSEcCtD
Sibutramine—Dry mouth—Donepezil—Alzheimer's disease	0.000166	0.000558	CcSEcCtD
Sibutramine—Body temperature increased—Galantamine—Alzheimer's disease	0.000166	0.000558	CcSEcCtD
Sibutramine—Abdominal pain—Galantamine—Alzheimer's disease	0.000166	0.000558	CcSEcCtD
Sibutramine—Tremor—Rivastigmine—Alzheimer's disease	0.000166	0.000557	CcSEcCtD
Sibutramine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000165	0.000552	CcSEcCtD
Sibutramine—Confusional state—Donepezil—Alzheimer's disease	0.000164	0.000551	CcSEcCtD
Sibutramine—Anaemia—Rivastigmine—Alzheimer's disease	0.000164	0.00055	CcSEcCtD
Sibutramine—Malaise—Memantine—Alzheimer's disease	0.000163	0.000549	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—CRH—Alzheimer's disease	0.000163	0.00417	CbGpPWpGaD
Sibutramine—Agitation—Rivastigmine—Alzheimer's disease	0.000163	0.000547	CcSEcCtD
Sibutramine—Oedema—Donepezil—Alzheimer's disease	0.000163	0.000547	CcSEcCtD
Sibutramine—Vertigo—Memantine—Alzheimer's disease	0.000163	0.000546	CcSEcCtD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	0.000163	0.00416	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	0.000163	0.00416	CbGpPWpGaD
Sibutramine—Syncope—Memantine—Alzheimer's disease	0.000163	0.000545	CcSEcCtD
Sibutramine—Leukopenia—Memantine—Alzheimer's disease	0.000162	0.000544	CcSEcCtD
Sibutramine—Infection—Donepezil—Alzheimer's disease	0.000162	0.000543	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000161	0.00412	CbGpPWpGaD
Sibutramine—Shock—Donepezil—Alzheimer's disease	0.00016	0.000538	CcSEcCtD
Sibutramine—Palpitations—Memantine—Alzheimer's disease	0.00016	0.000538	CcSEcCtD
Sibutramine—Malaise—Rivastigmine—Alzheimer's disease	0.00016	0.000537	CcSEcCtD
Sibutramine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00016	0.000535	CcSEcCtD
Sibutramine—Vertigo—Rivastigmine—Alzheimer's disease	0.000159	0.000535	CcSEcCtD
Sibutramine—Loss of consciousness—Memantine—Alzheimer's disease	0.000159	0.000535	CcSEcCtD
Sibutramine—Syncope—Rivastigmine—Alzheimer's disease	0.000159	0.000534	CcSEcCtD
Sibutramine—SLC6A3—Parkinsons Disease Pathway—CASP3—Alzheimer's disease	0.000159	0.00406	CbGpPWpGaD
Sibutramine—Cough—Memantine—Alzheimer's disease	0.000158	0.000531	CcSEcCtD
Sibutramine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000158	0.000529	CcSEcCtD
Sibutramine—Convulsion—Memantine—Alzheimer's disease	0.000157	0.000527	CcSEcCtD
Sibutramine—Palpitations—Rivastigmine—Alzheimer's disease	0.000157	0.000526	CcSEcCtD
Sibutramine—Hypertension—Memantine—Alzheimer's disease	0.000157	0.000525	CcSEcCtD
Sibutramine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000156	0.000523	CcSEcCtD
Sibutramine—Anorexia—Donepezil—Alzheimer's disease	0.000155	0.000521	CcSEcCtD
Sibutramine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000155	0.00052	CcSEcCtD
Sibutramine—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000155	0.00396	CbGpPWpGaD
Sibutramine—Cough—Rivastigmine—Alzheimer's disease	0.000155	0.000519	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—NPS—Alzheimer's disease	0.000155	0.00395	CbGpPWpGaD
Sibutramine—Myalgia—Memantine—Alzheimer's disease	0.000154	0.000518	CcSEcCtD
Sibutramine—Arthralgia—Memantine—Alzheimer's disease	0.000154	0.000518	CcSEcCtD
Sibutramine—Chest pain—Memantine—Alzheimer's disease	0.000154	0.000518	CcSEcCtD
Sibutramine—Anxiety—Memantine—Alzheimer's disease	0.000154	0.000516	CcSEcCtD
Sibutramine—Convulsion—Rivastigmine—Alzheimer's disease	0.000154	0.000516	CcSEcCtD
Sibutramine—Hypertension—Rivastigmine—Alzheimer's disease	0.000153	0.000514	CcSEcCtD
Sibutramine—Discomfort—Memantine—Alzheimer's disease	0.000152	0.000512	CcSEcCtD
Sibutramine—Hypotension—Donepezil—Alzheimer's disease	0.000152	0.000511	CcSEcCtD
Sibutramine—Myalgia—Rivastigmine—Alzheimer's disease	0.000151	0.000507	CcSEcCtD
Sibutramine—Chest pain—Rivastigmine—Alzheimer's disease	0.000151	0.000507	CcSEcCtD
Sibutramine—Arthralgia—Rivastigmine—Alzheimer's disease	0.000151	0.000507	CcSEcCtD
Sibutramine—Dry mouth—Memantine—Alzheimer's disease	0.000151	0.000506	CcSEcCtD
Sibutramine—Asthenia—Galantamine—Alzheimer's disease	0.000151	0.000506	CcSEcCtD
Sibutramine—Anxiety—Rivastigmine—Alzheimer's disease	0.00015	0.000505	CcSEcCtD
Sibutramine—SLC6A2—Monoamine Transport—TNF—Alzheimer's disease	0.00015	0.00382	CbGpPWpGaD
Sibutramine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—Alzheimer's disease	0.000149	0.00382	CbGpPWpGaD
Sibutramine—Confusional state—Memantine—Alzheimer's disease	0.000149	0.000501	CcSEcCtD
Sibutramine—Discomfort—Rivastigmine—Alzheimer's disease	0.000149	0.000501	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—SLC6A4—Alzheimer's disease	0.000149	0.00381	CbGpPWpGaD
Sibutramine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000148	0.000498	CcSEcCtD
Sibutramine—Oedema—Memantine—Alzheimer's disease	0.000148	0.000496	CcSEcCtD
Sibutramine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000148	0.000495	CcSEcCtD
Sibutramine—Insomnia—Donepezil—Alzheimer's disease	0.000147	0.000494	CcSEcCtD
Sibutramine—Infection—Memantine—Alzheimer's disease	0.000147	0.000493	CcSEcCtD
Sibutramine—SLC6A3—Neuronal System—CHRNA7—Alzheimer's disease	0.000147	0.00375	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GRIK1—Alzheimer's disease	0.000147	0.00375	CbGpPWpGaD
Sibutramine—Paraesthesia—Donepezil—Alzheimer's disease	0.000146	0.000491	CcSEcCtD
Sibutramine—Confusional state—Rivastigmine—Alzheimer's disease	0.000146	0.00049	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—HMOX1—Alzheimer's disease	0.000146	0.00372	CbGpPWpGaD
Sibutramine—Shock—Memantine—Alzheimer's disease	0.000146	0.000488	CcSEcCtD
Sibutramine—Dyspnoea—Donepezil—Alzheimer's disease	0.000145	0.000487	CcSEcCtD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.000145	0.00371	CbGpPWpGaD
Sibutramine—Somnolence—Donepezil—Alzheimer's disease	0.000145	0.000486	CcSEcCtD
Sibutramine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000145	0.000486	CcSEcCtD
Sibutramine—Oedema—Rivastigmine—Alzheimer's disease	0.000145	0.000486	CcSEcCtD
Sibutramine—Tachycardia—Memantine—Alzheimer's disease	0.000144	0.000484	CcSEcCtD
Sibutramine—Diarrhoea—Galantamine—Alzheimer's disease	0.000144	0.000483	CcSEcCtD
Sibutramine—Infection—Rivastigmine—Alzheimer's disease	0.000144	0.000482	CcSEcCtD
Sibutramine—Skin disorder—Memantine—Alzheimer's disease	0.000144	0.000482	CcSEcCtD
Sibutramine—Dyspepsia—Donepezil—Alzheimer's disease	0.000143	0.000481	CcSEcCtD
Sibutramine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000143	0.00048	CcSEcCtD
Sibutramine—Shock—Rivastigmine—Alzheimer's disease	0.000142	0.000478	CcSEcCtD
Sibutramine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000142	0.000475	CcSEcCtD
Sibutramine—Decreased appetite—Donepezil—Alzheimer's disease	0.000142	0.000475	CcSEcCtD
Sibutramine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000141	0.000474	CcSEcCtD
Sibutramine—Anorexia—Memantine—Alzheimer's disease	0.000141	0.000473	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000141	0.000472	CcSEcCtD
Sibutramine—Skin disorder—Rivastigmine—Alzheimer's disease	0.000141	0.000472	CcSEcCtD
Sibutramine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00014	0.000469	CcSEcCtD
Sibutramine—Constipation—Donepezil—Alzheimer's disease	0.000139	0.000468	CcSEcCtD
Sibutramine—Pain—Donepezil—Alzheimer's disease	0.000139	0.000468	CcSEcCtD
Sibutramine—Dizziness—Galantamine—Alzheimer's disease	0.000139	0.000467	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000139	0.00355	CbGpPWpGaD
Sibutramine—Hypotension—Memantine—Alzheimer's disease	0.000138	0.000464	CcSEcCtD
Sibutramine—Anorexia—Rivastigmine—Alzheimer's disease	0.000138	0.000463	CcSEcCtD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.000137	0.00351	CbGpPWpGaD
Sibutramine—Hypotension—Rivastigmine—Alzheimer's disease	0.000135	0.000454	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000135	0.000452	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.000135	0.00344	CbGpPWpGaD
Sibutramine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000134	0.000451	CcSEcCtD
Sibutramine—Insomnia—Memantine—Alzheimer's disease	0.000134	0.000449	CcSEcCtD
Sibutramine—Vomiting—Galantamine—Alzheimer's disease	0.000134	0.000449	CcSEcCtD
Sibutramine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000133	0.000447	CcSEcCtD
Sibutramine—Paraesthesia—Memantine—Alzheimer's disease	0.000133	0.000446	CcSEcCtD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—CP—Alzheimer's disease	0.000133	0.00339	CbGpPWpGaD
Sibutramine—Rash—Galantamine—Alzheimer's disease	0.000133	0.000445	CcSEcCtD
Sibutramine—SLC6A3—Monoamine Transport—TNF—Alzheimer's disease	0.000132	0.00339	CbGpPWpGaD
Sibutramine—Dermatitis—Galantamine—Alzheimer's disease	0.000132	0.000444	CcSEcCtD
Sibutramine—Dyspnoea—Memantine—Alzheimer's disease	0.000132	0.000443	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000132	0.000442	CcSEcCtD
Sibutramine—Headache—Galantamine—Alzheimer's disease	0.000132	0.000442	CcSEcCtD
Sibutramine—Somnolence—Memantine—Alzheimer's disease	0.000132	0.000441	CcSEcCtD
Sibutramine—Insomnia—Rivastigmine—Alzheimer's disease	0.000131	0.000439	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—AGER—Alzheimer's disease	0.000131	0.00334	CbGpPWpGaD
Sibutramine—Dyspepsia—Memantine—Alzheimer's disease	0.00013	0.000437	CcSEcCtD
Sibutramine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00013	0.000436	CcSEcCtD
Sibutramine—Urticaria—Donepezil—Alzheimer's disease	0.000129	0.000434	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.000129	0.00331	CbGpPWpGaD
Sibutramine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000129	0.000433	CcSEcCtD
Sibutramine—Abdominal pain—Donepezil—Alzheimer's disease	0.000129	0.000432	CcSEcCtD
Sibutramine—Body temperature increased—Donepezil—Alzheimer's disease	0.000129	0.000432	CcSEcCtD
Sibutramine—Somnolence—Rivastigmine—Alzheimer's disease	0.000129	0.000432	CcSEcCtD
Sibutramine—Decreased appetite—Memantine—Alzheimer's disease	0.000129	0.000432	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000128	0.000429	CcSEcCtD
Sibutramine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000127	0.000427	CcSEcCtD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000127	0.00325	CbGpPWpGaD
Sibutramine—Constipation—Memantine—Alzheimer's disease	0.000127	0.000424	CcSEcCtD
Sibutramine—Pain—Memantine—Alzheimer's disease	0.000127	0.000424	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—NGFR—Alzheimer's disease	0.000126	0.00323	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000126	0.00323	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	0.000126	0.00322	CbGpPWpGaD
Sibutramine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000126	0.000422	CcSEcCtD
Sibutramine—SLC6A2—NRF2 pathway—HMOX1—Alzheimer's disease	0.000125	0.0032	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.000125	0.0032	CbGpPWpGaD
Sibutramine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000125	0.000419	CcSEcCtD
Sibutramine—Nausea—Galantamine—Alzheimer's disease	0.000125	0.000419	CcSEcCtD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.000125	0.00319	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—CHAT—Alzheimer's disease	0.000125	0.00319	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GRIK2—Alzheimer's disease	0.000125	0.00319	CbGpPWpGaD
Sibutramine—Constipation—Rivastigmine—Alzheimer's disease	0.000124	0.000415	CcSEcCtD
Sibutramine—Pain—Rivastigmine—Alzheimer's disease	0.000124	0.000415	CcSEcCtD
Sibutramine—Feeling abnormal—Memantine—Alzheimer's disease	0.000122	0.000409	CcSEcCtD
Sibutramine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000121	0.000406	CcSEcCtD
Sibutramine—Hypersensitivity—Donepezil—Alzheimer's disease	0.00012	0.000403	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.00012	0.00306	CbGpPWpGaD
Sibutramine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000119	0.0004	CcSEcCtD
Sibutramine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000118	0.000397	CcSEcCtD
Sibutramine—Urticaria—Memantine—Alzheimer's disease	0.000118	0.000394	CcSEcCtD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—CP—Alzheimer's disease	0.000118	0.003	CbGpPWpGaD
Sibutramine—Abdominal pain—Memantine—Alzheimer's disease	0.000117	0.000392	CcSEcCtD
Sibutramine—Body temperature increased—Memantine—Alzheimer's disease	0.000117	0.000392	CcSEcCtD
Sibutramine—Asthenia—Donepezil—Alzheimer's disease	0.000117	0.000392	CcSEcCtD
Sibutramine—Pruritus—Donepezil—Alzheimer's disease	0.000115	0.000387	CcSEcCtD
Sibutramine—Urticaria—Rivastigmine—Alzheimer's disease	0.000115	0.000386	CcSEcCtD
Sibutramine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000115	0.00294	CbGpPWpGaD
Sibutramine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000114	0.000384	CcSEcCtD
Sibutramine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000114	0.000384	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000114	0.00291	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—PPARGC1A—Alzheimer's disease	0.000113	0.00289	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—AGER—Alzheimer's disease	0.000112	0.00288	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000112	0.00286	CbGpPWpGaD
Sibutramine—Diarrhoea—Donepezil—Alzheimer's disease	0.000111	0.000374	CcSEcCtD
Sibutramine—SLC6A3—Neuronal System—GRIA1—Alzheimer's disease	0.000111	0.00284	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—HMOX1—Alzheimer's disease	0.000111	0.00283	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	0.00011	0.00281	CbGpPWpGaD
Sibutramine—Hypersensitivity—Memantine—Alzheimer's disease	0.000109	0.000366	CcSEcCtD
Sibutramine—Dizziness—Donepezil—Alzheimer's disease	0.000108	0.000362	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000107	0.00274	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	0.000107	0.00274	CbGpPWpGaD
Sibutramine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000107	0.000358	CcSEcCtD
Sibutramine—Asthenia—Memantine—Alzheimer's disease	0.000106	0.000356	CcSEcCtD
Sibutramine—SLC6A3—Neuronal System—CHRNB2—Alzheimer's disease	0.000105	0.00269	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	0.000105	0.00268	CbGpPWpGaD
Sibutramine—Pruritus—Memantine—Alzheimer's disease	0.000105	0.000351	CcSEcCtD
Sibutramine—Asthenia—Rivastigmine—Alzheimer's disease	0.000104	0.000348	CcSEcCtD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	0.000104	0.00265	CbGpPWpGaD
Sibutramine—Vomiting—Donepezil—Alzheimer's disease	0.000104	0.000348	CcSEcCtD
Sibutramine—Rash—Donepezil—Alzheimer's disease	0.000103	0.000345	CcSEcCtD
Sibutramine—Dermatitis—Donepezil—Alzheimer's disease	0.000103	0.000344	CcSEcCtD
Sibutramine—Pruritus—Rivastigmine—Alzheimer's disease	0.000102	0.000344	CcSEcCtD
Sibutramine—Headache—Donepezil—Alzheimer's disease	0.000102	0.000343	CcSEcCtD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000101	0.00259	CbGpPWpGaD
Sibutramine—Diarrhoea—Memantine—Alzheimer's disease	0.000101	0.00034	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—PRKCG—Alzheimer's disease	0.0001	0.00256	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—AGER—Alzheimer's disease	9.96e-05	0.00255	CbGpPWpGaD
Sibutramine—Diarrhoea—Rivastigmine—Alzheimer's disease	9.9e-05	0.000332	CcSEcCtD
Sibutramine—Dizziness—Memantine—Alzheimer's disease	9.78e-05	0.000328	CcSEcCtD
Sibutramine—Nausea—Donepezil—Alzheimer's disease	9.68e-05	0.000325	CcSEcCtD
Sibutramine—SLC6A3—Neuronal System—ACHE—Alzheimer's disease	9.66e-05	0.00247	CbGpPWpGaD
Sibutramine—Dizziness—Rivastigmine—Alzheimer's disease	9.57e-05	0.000321	CcSEcCtD
Sibutramine—SLC6A3—Neuronal System—CHRNA4—Alzheimer's disease	9.55e-05	0.00244	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—APOD—Alzheimer's disease	9.51e-05	0.00243	CbGpPWpGaD
Sibutramine—Vomiting—Memantine—Alzheimer's disease	9.41e-05	0.000316	CcSEcCtD
Sibutramine—Rash—Memantine—Alzheimer's disease	9.33e-05	0.000313	CcSEcCtD
Sibutramine—Dermatitis—Memantine—Alzheimer's disease	9.32e-05	0.000313	CcSEcCtD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	9.3e-05	0.00238	CbGpPWpGaD
Sibutramine—Headache—Memantine—Alzheimer's disease	9.27e-05	0.000311	CcSEcCtD
Sibutramine—Vomiting—Rivastigmine—Alzheimer's disease	9.2e-05	0.000309	CcSEcCtD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	9.18e-05	0.00235	CbGpPWpGaD
Sibutramine—Rash—Rivastigmine—Alzheimer's disease	9.13e-05	0.000306	CcSEcCtD
Sibutramine—Dermatitis—Rivastigmine—Alzheimer's disease	9.12e-05	0.000306	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	9.09e-05	0.00232	CbGpPWpGaD
Sibutramine—Headache—Rivastigmine—Alzheimer's disease	9.07e-05	0.000304	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	9.03e-05	0.00231	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	8.91e-05	0.00228	CbGpPWpGaD
Sibutramine—Nausea—Memantine—Alzheimer's disease	8.79e-05	0.000295	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—LEP—Alzheimer's disease	8.64e-05	0.00221	CbGpPWpGaD
Sibutramine—Nausea—Rivastigmine—Alzheimer's disease	8.6e-05	0.000288	CcSEcCtD
Sibutramine—SLC6A3—Neuronal System—BCHE—Alzheimer's disease	8.42e-05	0.00215	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—DLG4—Alzheimer's disease	8.22e-05	0.0021	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—NOS2—Alzheimer's disease	8.05e-05	0.00206	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GRIN2B—Alzheimer's disease	8.03e-05	0.00205	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—PLCB1—Alzheimer's disease	7.94e-05	0.00203	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	7.69e-05	0.00197	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	7.67e-05	0.00196	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	7.54e-05	0.00193	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—PPARG—Alzheimer's disease	7.53e-05	0.00192	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—GSK3B—Alzheimer's disease	7.48e-05	0.00191	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—CREB1—Alzheimer's disease	7.42e-05	0.0019	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	7.28e-05	0.00186	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	6.75e-05	0.00172	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—CP—Alzheimer's disease	6.74e-05	0.00172	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	6.73e-05	0.00172	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	6.63e-05	0.0017	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—CP—Alzheimer's disease	5.97e-05	0.00153	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—PRKCG—Alzheimer's disease	5.87e-05	0.0015	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—TF—Alzheimer's disease	5.73e-05	0.00147	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	5.71e-05	0.00146	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	5.68e-05	0.00145	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—TGFB1—Alzheimer's disease	5.53e-05	0.00141	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	5.39e-05	0.00138	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—CALM1—Alzheimer's disease	5.08e-05	0.0013	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—TF—Alzheimer's disease	5.08e-05	0.0013	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—MAPK8—Alzheimer's disease	5.05e-05	0.00129	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	4.9e-05	0.00125	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—TGFB1—Alzheimer's disease	4.75e-05	0.00122	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—CREB1—Alzheimer's disease	4.35e-05	0.00111	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—TGFB1—Alzheimer's disease	4.21e-05	0.00108	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	4.08e-05	0.00104	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	4.01e-05	0.00102	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	4e-05	0.00102	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	3.95e-05	0.00101	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	3.95e-05	0.00101	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	3.55e-05	0.000908	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—TP53—Alzheimer's disease	3.52e-05	0.000901	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—IL6—Alzheimer's disease	3.23e-05	0.000825	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	2.31e-05	0.000592	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.97e-05	0.000503	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.85e-05	0.000473	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.75e-05	0.000448	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.67e-05	0.000428	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.6e-05	0.00041	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.54e-05	0.000395	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.49e-05	0.000381	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	9.61e-06	0.000246	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	9.61e-06	0.000246	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	9.22e-06	0.000236	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	8.87e-06	0.000227	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—A2M—Alzheimer's disease	8.57e-06	0.000219	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	7.45e-06	0.00019	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	7.37e-06	0.000188	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	6.98e-06	0.000179	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	6.98e-06	0.000179	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	6.85e-06	0.000175	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	6.49e-06	0.000166	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	6.13e-06	0.000157	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	5.94e-06	0.000152	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	5.12e-06	0.000131	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	5.09e-06	0.00013	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—LPL—Alzheimer's disease	4.66e-06	0.000119	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	4.2e-06	0.000107	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	3.92e-06	0.0001	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APOE—Alzheimer's disease	3.91e-06	9.98e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	3.87e-06	9.89e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	3.4e-06	8.7e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—INS—Alzheimer's disease	3.34e-06	8.53e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.93e-06	7.48e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.68e-06	6.84e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.35e-06	3.44e-05	CbGpPWpGaD
